Company profile
Botanix Pharmaceuticals
Botanix Pharmaceuticals (ASX:BOT) is a commercial dermatology company that has launched FDA-approved Sofdra in the US
- Industry
- Pharmaceutical Manufacturing
- Employees
- 72
- Headquarters
- Melbourne, VIC
- LinkedIn followers
- 6,427
- Office locations
- 2
Botanix Pharmaceuticals company summary
Botanix Pharmaceuticals is a company in the Pharmaceutical Manufacturing industry, headquartered in Melbourne, VIC. On LinkedIn the company has around 72 employees and 6,427 followers. The company lists 2 office locations. Its listed specialties include Medical dermatology and hyperhidrosis.
What technology does Botanix Pharmaceuticals use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Botanix Pharmaceuticals
Botanix Pharmaceuticals Limited is an ASX-listed (ASX:BOT) dermatology company with its US headquarters in Phoenix, AZ, that is committed to the development and commercialisation of novel treatments for common skin diseases. In June 2024, Botanix received FDA approval for Sofdra, its product for the treatment of excessive underarm sweating (primary axillary hyperhidrosis), and successfully launched it in the US in February 2025. Sofdra is the first and only new chemical entity approved by FDA to treat primary axillary hyperhidrosis and presents a novel, safe and effective solution for patients who have lacked treatment options for this socially challenging medical condition. Primary axillary hyperhidrosis is a medical condition where excessive sweating occurs beyond what is needed to maintain body temperature, which impacts the lives of approximately 10 million people in the US alone. Botanix has attracted a world-class team and significant capital to support the commercialization of Sofdra.
Specialties
Where is Botanix Pharmaceuticals located?
Botanix Pharmaceuticals lists 2 office locations.
Compare companies similar to Botanix Pharmaceuticals
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Botanix Pharmaceuticals botanixpharma.com | Pharmaceutical Manufacturing | 72 | - | Melbourne, VIC |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Botanix Pharmaceuticals
What does Botanix Pharmaceuticals do?
Botanix Pharmaceuticals Limited is an ASX-listed (ASX:BOT) dermatology company with its US headquarters in Phoenix, AZ, that is committed to the development and commercialisation of novel treatments for common skin diseases. In June 2024, Botanix received FDA approval for Sofdra, its product for the treatment of excessive underarm sweating (primary axillary hyperhidrosis), and successfully launched it in the US in February 2025. Sofdra is the first and only new chemical entity approved by FDA to treat primary axillary hyperhidrosis and presents a novel, safe and effective solution for patients who have lacked treatment options for this socially challenging medical condition. Primary axillary hyperhidrosis is a medical condition where excessive sweating occurs beyond what is needed to maintain body temperature, which impacts the lives of approximately 10 million people in the US alone. Botanix has attracted a world-class team and significant capital to support the commercialization of Sofdra.
How many employees does Botanix Pharmaceuticals have?
Botanix Pharmaceuticals has around 72 employees on LinkedIn.
Where is Botanix Pharmaceuticals headquartered?
Botanix Pharmaceuticals is headquartered in Melbourne, VIC.
Where does Botanix Pharmaceuticals have offices?
Botanix Pharmaceuticals lists 2 office locations, including Melbourne, VIC, AU; Phoenix, Arizona, US.
Build a lead list from companies like Botanix Pharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.